Carlsmed Inc is a commercial-stage medical technology company focused on developing AI-enabled personalized solutions for spine surgery... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
CARL is expected to report earnings to rise 5.13% to -40 cents per share on November 05
Q3'26
Est.
$-0.41
Q2'26
Est.
$-0.39
Q1'26
Beat
by $0.05
Q4'25
Beat
by $0.03
The last earnings report on August 05 showed earnings per share of -38 cents, meeting the estimate of -38 cents. With 154.08K shares outstanding, the current market capitalization sits at 438.21M.